News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why Is Gilead (GILD) On Fire?



9/1/2017 6:06:34 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Since the acquisition of Kite Pharma for $11.9B by Gilead (NASDAQ:GILD) on Monday, the whole perception of Gilead and the stock has changed for investors. Gilead is no longer a beaten-down value stock due to slumping HCV sales and an unclear path toward future growth. For the last three years (Figure 1), Gilead has greatly underperformed IBB and the S&P and has been a letdown for many investors and optimists.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES